- Home
- COE vs CVRX Comparison
COE vs CVRX Comparison
Compare COE & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COE | CVRX |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | Singapore | United States |
| Employees | N/A | 223 |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.9M | 151.7M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | COE | CVRX |
|---|---|---|
| Price | $27.25 | $6.06 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | 5.8K | ★ 349.0K |
| Earning Date | 06-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,651,000.00 |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $17.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $15.32 | $4.37 |
| 52 Week High | $56.13 | $11.30 |
Technical Indicators
Market Signals| Indicator | COE | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.51 | 39.85 |
| Support Level | $26.90 | $4.83 |
| Resistance Level | $27.63 | $8.25 |
| Average True Range (ATR) | 1.53 | 0.62 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 71.68 | 33.76 |
Price Performance
Historical ComparisonAbout COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.